Industry Sponsored and Diabetes Educator Section (DES) Events

The following is a list of current industry sponsored events we have been made aware of at Diabetes Centre Calgary for health care professionals only. We cannot speak to the validity or relevance of information presented and do not accept responsibility for any aspect of these events. Health care professionals choosing to attend industry sponsored events are encouraged to use professional judgment and critically evaluate data presented. We advise health care professionals discuss attendance and/or participation at industry sponsored events with their management team if concerned about possible conflict of interest. Please note, we will delete past events. 


No date limit: Lifescan Diabetes Institute Webinars 

Lifescan is sponsoring a number of different educational webinars. Topics include smartphone technology for diabetes management, supporting sustained behaviour change, and many more. Webinars are recorded and can be viewed at your convenience. For more information visit: 


November 21: Abbott Sponsored Webinar: Nutrition Therapies for Type 2 Diabetes 

Abbott event

Note: the "Click Here to Register" box does not function in above image. Please visit to register. 


 November 18, 21, 22, 26, 27, 28: Libre Scanning with Meaning Module 3 - Beyond A1c

This is the final webinar of a three-part series that examines the latest innovation in diabetes care: flash glucose monitoring. Register now for the third module and learn how to help your patients understand and get the most from the data generated by the FreeStyle Libre system. Visit: 


Overview of GLP-1 Receptor Agonists

Dec 12, 2019 at 12:00 pm. Offered by the First Nations Telehealth Network, and sponsored by Novo Nordisk. Presented by Dr Jeff Winterstein. For more information, and to register, please go to or call 1-888-999-3356.


  • Type 2 diabetes and Indigenous peoples
  • Overview of GLP-1 class
  • Practical strategies to incorporate GLP1 therapies in patients with type 2 diabetes
  • Discuss patient access to GLP1 therapy through the NIHB program.